Professional consulting, outstanding products, service and support.
All the facts about the TELES share
All of the important dates in the current fiscal year.
All the facts about the General Meeting of shareholders
Easy access to our downloadable financial reports
July 22, 2013
Restructuring is clearly making progress
April 22, 2013
Fundamental earnings improvement, slight decrease in turnover
April 09, 2013
Slight increase in sales YOY, robust earnings improvement
April 02, 2013
TELES to give up remaining stake in Gravis Beteiligungs AG
November 12, 2012
Increase in revenues and gross profit, outlook confirmed
All News
TELES AG: Admission of 1,001,210 shares 04.04.2024
TELES AG: Admission of 834,342 shares 08.02.2023
TELES Aktiengesellschaft: TELES with a further jump in sales – Pharma is growing rapidly 07.11.2022
TELES Aktiengesellschaft: Record sales from pharmaceuticals with more than 39 million (previous year: KEUR 1,224) in the first half of the year 01.08.2022
TELES Aktiengesellschaft Informationstechnologien: Pharma drives sales to more than EUR 19 million (previous year: EUR 540 thousand) in the first quarter 16.05.2022
TELES sales forecast 2022: More than EUR 55 million expected (2020: EUR 2.8 million) 16.12.2021